###begin article-title 0
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 216 223 <span type="species:ncbi:9606">infants</span>
###xml 232 260 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 267 272 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 397 402 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 460 <span type="species:ncbi:9606">infants</span>
###xml 552 557 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HLA-G gene is a non-classical MHC class 1 molecule that is highly expressed in the trophoblast at the maternal-fetal interface. In an attempt to elucidate possible immunological mechanisms facilitating protection of infants born to human immunodeficiency virus type (HIV-1) infected mothers, we have been studying genetic variations in the coding and untranslated regions of HLA-G antigen between HIV-1-infected mothers and their infected or uninfected infants. This study investigated whether HLA-G DNA sequence variants are associated with perinatal HIV-1 transmission.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 436 442 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 80 85 <span type="species:ncbi:9606">child</span>
###xml 308 313 <span type="species:ncbi:9606">child</span>
###xml 319 324 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 395 400 <span type="species:ncbi:9606">child</span>
Genomic DNA samples were obtained from a nested case-control study of 34 mother-child pairs co-enrolled in a cohort of the Perinatal AIDS Collaborative Transmission Study in New York. The samples were from two groups predominantly of African-American and Hispanic origin: In the first group, both mother and child were HIV-1-infected; in the second group, only the mother was infected while the child remained uninfected. Genotyping of HLA-G gene were performed on the extracted DNA from peripheral blood mononuclear cells using PCR based sequencing and restriction fragment-length polymorphism analyses.
###end p 5
###begin p 6
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA</italic>
###xml 22 24 22 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G </italic>
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 530 532 530 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 120 125 <span type="species:ncbi:9606">child</span>
###xml 263 268 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 276 281 <span type="species:ncbi:9606">child</span>
###xml 384 389 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 418 423 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 444 449 <span type="species:ncbi:9606">child</span>
###xml 701 706 <span type="species:ncbi:9606">child</span>
###xml 720 725 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 820 825 <span type="species:ncbi:9606">child</span>
Among the studied HLA-G exons, dissimilarities in HLA-G DNA sequence variants between the HIV-1 non-transmitting mother child pairs were mostly observed in exon 8-3'-untranslated region at nucleotide positions T3742A, C3743T, G3777C (P = 0.001). Non-transmitting HIV-1 mother child pairs exhibited dissimilarities at nucleotide position C3743T allele with decreased risk of perinatal HIV-1 transmission, compared with HIV-1 transmitting mother-child pairs carrying this allele (odds ratio 0.02 [95% confidence interval 0.00-0.15] P = 0.00001). In addition, heterozygous dissimilarities at nucleotide positions C634G and 714 insT/G in the 5'-upstream regulatory region were observed between the mother child pairs of the HIV-1-non-transmitting group while homozygous similarities of C634C, and either 714insG/G or mother-child pairs with similar 714insT/G were observed among the transmitting group in the same region.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 175 180 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 212 219 <span type="species:ncbi:9606">infants</span>
This study identified new variants in the HLA-G gene and provides further evidence that dissimilarities in the HLA-G DNA sequence variants could influence the transmission of HIV-1 from infected mothers to their infants.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1149 1150 1149 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1151 1152 1151 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 16 19 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 230 233 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 394 399 <span type="species:ncbi:9606">women</span>
###xml 1198 1203 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mother-to-child HIV transmission (MTCT) can occur during pregnancy, labor and postnatally through breastfeeding [1,2]. In developed countries, MTCT has decreased to approximately 1 or 2% after implementation of universal prenatal HIV counseling and testing, antiretroviral prophylaxis, elective cesarean delivery and avoidance of breastfeeding [3]. Antiretroviral therapy for infected pregnant women has significantly reduced the risk of MTCT in developing countries. However, factors primarily related to logistics, costs and access have limited the impact of these interventions in developing countries. Although it remains important to continue to pursue strategies to make effective antiretroviral interventions available in developing countries, an efficacious vaccine would surely be highly valuable for reduction of MTCT and certainly would be the best strategy for reducing infection spread worldwide among adults. The development of an effective vaccine would be greatly assisted by better understanding of the molecular genetic mechanisms of transmission, including for example, if the host gene immune responses involving the chemokines [4,5], and HLA polymorphisms are involved in host-HIV-1 interactions.
###end p 10
###begin p 11
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 316 322 316 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 773 778 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 926 927 926 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 935 940 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1093 1097 1093 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA </italic>
###xml 1107 1108 1107 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1877 1878 1877 1878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1879 1881 1879 1881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1935 1941 1935 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 463 468 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 624 629 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 717 725 <span type="species:ncbi:9606">children</span>
###xml 851 856 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1128 1133 <span type="species:ncbi:9606">child</span>
###xml 1150 1155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1184 1189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1201 1206 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1395 1401 <span type="species:ncbi:9606">infant</span>
###xml 1578 1583 <span type="species:ncbi:9606">child</span>
###xml 1847 1852 <span type="species:ncbi:9606">child</span>
###xml 1980 1985 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human leukocyte antigen G (HLA-G), a non-classical class 1 MHC gene, is highly expressed in trophoblast at the maternal-fetal interface. The unique expression of this gene in the trophoblast at the maternal-fetal interface indicates a critical role for this locus in human pregnancy. Past studies [6-8] suggest that HLA-G gene protects the trophoblast from maternal T-cell and natural killer cell (NK) mediated lysis. However, association of this HLA-G gene with HIV-1 infection or transmission is yet to be fully determined. Several lines of evidence suggest that fetal or newborn alloimmune responses directed at maternal HIV-1-infected cells or at free virus bearing maternal MHC determinants may account for some children remaining uninfected [9-11]. A study by Arthur et al., [12] showed that class 1 MHC antigens were present on the envelope of HIV-1 and that the antisera to these proteins precipitated intact virions [7]. Chan et al., [13] observed that immunization with purified class 1 HLA molecules could protect macaques from challenge with cell-free virus expressing the class 1 HLA peptides [9]. During mother-to-child transmission of HIV-1, it is unclear whether free HIV-1 virions or HIV-1-infected cells of maternal origin or both are present in the maternal MHC antigens. It is possible that either fetal or newborn anti-MHC or alloreactive T cell responses could protect the infant against infection transmitted from the mother. However, such mechanisms would only be operative if there were some degree of HLA-G sequence variants between the mother and the child. The effects would depend on mechanisms and changes in the function that resulted from the HLA-G sequence variants. Moreover, it could reasonably be expected that any protection provided may correlate with the extent of HLA discordance between the mother and the child as previously reported [9-11]. This study was designed to examine variants in the HLA-G gene that may play a role in perinatal HIV-1 transmission.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Study participation
###end title 13
###begin p 14
###xml 92 104 <span type="species:ncbi:9606">participants</span>
###xml 245 248 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 344 347 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 364 371 <span type="species:ncbi:9606">infants</span>
###xml 399 404 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 414 421 <span type="species:ncbi:9606">infants</span>
###xml 444 456 <span type="species:ncbi:9606">participants</span>
###xml 523 528 <span type="species:ncbi:9606">child</span>
###xml 654 659 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 669 676 <span type="species:ncbi:9606">infants</span>
A nested case-control study designed with subjects and controls were selected from enrolled participants that were previously followed as a part of Perinatal AIDS Collaborative Transmission Study (PACTS), a multi-center cohort study of vertical HIV transmission, funded by Centers for Disease Control and Prevention (CDC), which enrolled 2,665 HIV-positive mother-infants between 1986 and 1998 (360 HIV-1-infected infants). In this study, only participants enrolled in New York City were part of the selection of 34 mother-child pairs. Generally, PACTS cohorts collected early neonatal PCR data (< 48-72 hours after birth) and classified the perinatally HIV-1-infected infants in the cohort as: 1) intrauterine infection (DNA PCR positive < 48 hours) and 2) presumed peripartum infection (intrapartum and/or very late interuterine). The study protocols have been approved by institutional review boards at the respective participating sites including the CDC. Written informed consent were obtained from mothers who participated in this study.
###end p 14
###begin title 15
Participation criteria
###end title 15
###begin p 16
###xml 504 506 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 573 575 573 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 632 634 632 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 821 823 821 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 875 876 875 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 880 882 880 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 948 950 948 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1138 1140 1138 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1296 1298 1296 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 33 40 <span type="species:ncbi:9606">infants</span>
###xml 82 90 <span type="species:ncbi:9606">Children</span>
###xml 130 135 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 223 228 <span type="species:ncbi:9606">child</span>
###xml 409 415 <span type="species:ncbi:9606">infant</span>
###xml 416 428 <span type="species:ncbi:9606">participants</span>
###xml 476 481 <span type="species:ncbi:9606">child</span>
###xml 536 541 <span type="species:ncbi:9606">child</span>
###xml 727 734 <span type="species:ncbi:9606">infants</span>
###xml 774 779 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 840 845 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1098 1103 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1157 1162 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Blood samples were obtained from infants who were at least after 2 months of age. Children known to have been breast-fed or whose HIV-1 status could not be determined were excluded. Also, all blood samples were from mother-child pairs who were not treated with antiretroviral drugs. The majority of samples included in this study were African American (59%) and Hispanic (29%). The mean birthweight among the infant participants were 2715 grams in the non-transmitting mother-child pairs and 2607 grams (p = 0.3) in transmitting mother-child pairs and the mean maternal CD4+ T-lymphocyte count were 579 copies/mL and 488 copies/mL (p = 0.2) in the non-transmitting and transmitting groups respectively. Preterm delivery of the infants (< 37 weeks) were 29% (4/14) among the HIV-1-non-transmitting mothers and 30% (6/20) (p = 0.8) among the HIV-1-transmitting mothers. The CD4+:CD8+ ratio was 0.9 [(0.61), 21.4% (3/14)] and 0.59 [(0.36) 5% (1/20)] (p = 0.5) among the non-transmitting and transmitting mothers respectively. In addition, rupture of membranes during delivery was 50% (7/14) among the HIV-1-non-transmitting and 55% (11/20) (p = 0.9) among the HIV-1-transmitting mothers. Mothers diagnosed with AIDS before delivery were 21.4% (3/14) among the non-transmitting group and 25% (5/20) (p = 0.8) among transmitting group.
###end p 16
###begin title 17
Study protocol
###end title 17
###begin p 18
###xml 639 641 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 118 125 <span type="species:ncbi:9606">infants</span>
###xml 130 135 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 153 161 <span type="species:ncbi:9606">Children</span>
###xml 298 306 <span type="species:ncbi:9606">children</span>
###xml 383 391 <span type="species:ncbi:9606">children</span>
###xml 430 435 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 616 619 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Genomic DNA samples were isolated from the blood drawn within 48 hours to 18 months after birth from the participated infants for HIV-1 PCR-based tests. Children enrolled in this study were tested again at months 1, 2, 4, and 6 and at a month interval thereafter. The cohorts followed all infected children and examined them at regular intervals according to the standard protocols: children were considered infected if they were HIV-1-seropositive, confirmed by western blot at >/=18 months of age, had two or more positive PCR tests or viral cultures at any age, had an AIDS-defining illness, or if they died with HIV-related condition [14].
###end p 18
###begin title 19
Sample source and DNA extraction
###end title 19
###begin p 20
###xml 60 65 <span type="species:ncbi:9606">child</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 113 118 <span type="species:ncbi:9606">child</span>
###xml 160 165 <span type="species:ncbi:9606">child</span>
Extracted DNA were obtained from blood samples of 34 mother-child pairs, which included 20 HIV-1-infected mother-child pairs, and 14 infected mother-uninfected child pairs. Briefly, blood samples were collected in vacutainer collection tubes containing EDTA anticoagulant. Plasma and peripheral blood mononuclear cell (PBMC) fractions were prepared by Ficoll-Hypaque centrifugation. Cells in the PBMC fraction were washed in phosphate buffered saline (PBS). The PBMCs were lysed and genomic DNA were purified using the QIAamp blood PCR Kit (Qiagen, Chatsworth, CA), and quantified by UV absorption spectrometry. DNA was stored at -20degreesC.
###end p 20
###begin title 21
Amplification of HLA-G exons, intron, 5'URR and 8-3'UTR
###end title 21
###begin p 22
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 433 440 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5hlag1F</italic>
###xml 442 444 442 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5'</italic>
###xml 445 470 445 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GGGTTTCTC CCTGGTTTCTC-3' </italic>
###xml 484 515 484 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3hlagex1R 5-CGAGGAGGGGTTGAGACC </italic>
###xml 621 629 621 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5hlaf6/7</italic>
###xml 631 659 631 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5'-TTCCTCTAGGACCTCATGGCC-3' </italic>
###xml 673 710 673 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3hlagex8 5'-AGGAAAGGTG ATTGGGGAAG-3' </italic>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1106 1110 1104 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 56 61 <span type="species:ncbi:9606">child</span>
Isolated genomic DNA samples from HIV-1-infected mother/child pairs were amplified using HLA-G allele-specific primers as previously described [7,15] for exons 3, and 4. Extensive care was taken to design primers for 5'untranslated regulatory region (5'URR) and primers spanning exons 6, 7 and 8-3' untranslated regions (8-3'UTR) using previously described nucleotide sequence of HLA-6.0 by Geraghty et al. [16]. Primers for 5'URR, (5hlag1F: 5'-GGGTTTCTC CCTGGTTTCTC-3' (forward) and 3hlagex1R 5-CGAGGAGGGGTTGAGACC -3' (reverse)), generated a 550-bp fragment as a part of 5'URR that spanned exon 1. Primers for 8-3'UTR, (5hlaf6/7: 5'-TTCCTCTAGGACCTCATGGCC-3' (forward) and 3hlagex8 5'-AGGAAAGGTG ATTGGGGAAG-3' (reverse)), generated a 590-bp fragment that spanned exons 6, 7, intron 7, exon 8 and a part of the 3'-UTR. The conditions for the amplification reactions for exons 3, 4 were as previously described [15] and the conditions for the amplification reactions for 5'URR and 8-3'UTR fragments, were as follows: 100 ng of DNA, 1 muM of each primer: 200 muM of each dNTP (Promega, Madison, WI) and 0.5 U Taq polymerase in 10x buffer (Fisher Scientific, Suwanee, GA). The 5'URR and 8-3'UTR PCR procedure was as follows: an initial denaturation step at 95degreesC for 5 min, and amplification for 35 cycles at 94degreesC for 1 min, 60degreesC for 1 min, 72degreesC for 1.30 min, followed by a final extension step at 72degreesC for 10 min, except, for 5'URR, the annealing was 64degreesC for 45 sec. PCR products were electrophoresed on 1% agarose gel.
###end p 22
###begin title 23
Sequencing and statistical analysis
###end title 23
###begin p 24
###xml 326 335 326 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5HLAGPRO </italic>
###xml 337 363 337 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-GGCTCTCAGGG TCTCAGGCCCCAC</italic>
###xml 380 416 380 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLAGEX1REV 5'-GGCCGTTTCCCTCCTGAC-3' </italic>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 793 797 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst </italic>
###xml 1202 1203 1202 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1082 1087 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1129 1134 <span type="species:ncbi:9606">child</span>
###xml 1440 1445 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1487 1492 <span type="species:ncbi:9606">child</span>
All PCR products were purified using Qiagen gel extraction Kits (Chatsworth, CA). Sequencing was performed in both directions by Big Dye Terminator v.3 (Applied Biosystems) on an ABI 3100 Automated sequencer (Applied Biosystems), using PCR primers for all studied exons and internal sequencing primers specifically for 5'URR (5HLAGPRO 5'-GGCTCTCAGGG TCTCAGGCCCCAC-3'(forward) and HLAGEX1REV 5'-GGCCGTTTCCCTCCTGAC-3' (reverse)). Sequencing results were analyzed using nucleotide-nucleotide BLAST searches. Also, sequences were aligned with previously published nucleotide sequences of Geraghty et al.,[16]. Restriction analysis was used to validate all sequence variants including the amplified PCR products spanning exons 6, 7 and 8 including intron 7 and part of 3-UTR that was digested with Pst I enzyme according to the manufacture's instructions (Promega). The digested products were subjected to 2% agarose gel electrophoresis and detected by staining with ethidium bromide. To assess differences between proportions in each of the HLA-G variant within each studied exon among HIV-1 non-transmitting and transmitting mother-child pairs, Fisher' exact test was applied with corresponding two-sided p-values, odds ratio (OR) and 95% confidence intervals (CIs). To assess overall difference between the exons, Pearson Chi-square test was used with respect to frequencies of the HLA-G DNA sequence similarities and dissimilarities between HIV-1 non-transmitting and transmitting mother-child pairs within and among exons and results were declared significant at an alpha = 0.05 using the SAS release 9.1.
###end p 24
###begin title 25
Definitions of similarity/dissimilarity HLA-G DNA sequence variant
###end title 25
###begin p 26
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 717 723 717 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 7 12 <span type="species:ncbi:9606">child</span>
###xml 96 101 <span type="species:ncbi:9606">child</span>
###xml 293 298 <span type="species:ncbi:9606">child</span>
###xml 377 382 <span type="species:ncbi:9606">child</span>
###xml 528 533 <span type="species:ncbi:9606">child</span>
###xml 679 684 <span type="species:ncbi:9606">child</span>
Mother-child pairs were considered similar in HLA-G DNA sequence variant if both the mother and child were homozygous for that allele, heterozygous for the same variant within each of the studied exons, with reference to previously published HLA-G DNA sequence by Geraghty et al.,[16]. Mother-child pairs who shared only one variant that is heterozygous, or pairs in which the child was homozygous for that allele while the mother was not, was considered as dissimilarity of the HLA-G DNA sequence variants. Furthermore, mother-child pairs was defined as a HLA-G DNA sequence variant dissimilar if no shared HLA-G DNA sequence variants were identified between the mother and the child within the studied exons of the HLA-G gene.
###end p 26
###begin title 27
Results and discussion
###end title 27
###begin p 28
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 30 35 <span type="species:ncbi:9606">child</span>
###xml 116 121 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 168 <span type="species:ncbi:9606">children</span>
###xml 197 205 <span type="species:ncbi:9606">children</span>
###xml 215 220 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Thirty-four samples of mother-child pairs (68 samples) were selected as described above, which included 14 pairs of HIV-1-infected mothers and their uninfected children and 20 pairs of mothers and children who were HIV-1-infected. Analysis of the HLA-G DNA sequences of exons 2, 3, 4, 6, 7, a part of 8-3'UTR and a part of 5'URR spanning exon 1 from these samples was performed. All sequences and positions were referenced with the wild-type HLA-G sequence of Geragthy et al., [16]. Twenty-one HLA-G sequence variants were observed as shown in Table 1. Seven out of 21 (33%) of the observed variants were previously described [7,8,14,18,19]. Fourteen out of 21 (67%) variants, (G634C, 714insT, C1486G, C1486A, G2575A, T2577A, C2614A, C2622A, 3401insC, G3579A, G3585T, C3619G, T3742A, and C3743T) (Table 1; Figures 1 and 2), were not previously reported.
###end p 28
###begin p 29
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 95 100 <span type="species:ncbi:9606">child</span>
Variations in HLA-G DNA sequence observed among HIV-1-transmitting and non-transmitting mother-child pairs.
###end p 29
###begin p 30
*Polymorphisms are indicated with reference to the wild-type HLA 6.0 sequence previously published by Geraghty (1987).
###end p 30
###begin p 31
###xml 144 147 144 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-B</bold>
###xml 301 306 299 304 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C-D: </bold>
###xml 368 369 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 417 426 415 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCAAT box</italic>
###xml 249 254 <span type="species:ncbi:9606">child</span>
###xml 271 276 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 509 514 <span type="species:ncbi:9606">child</span>
###xml 528 533 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 591 596 <span type="species:ncbi:9606">child</span>
Sequence electropherograms obtained from HLA-G DNA 5' untranslated regulatory region showing polymorphisms at nucleotide positions 634 and 714. A-B: Reverse strand sequences and arrows indicating a nucleotide change of C-->G observed between mother-child pairs among the HIV-1 non-transmitting group. C-D: Forward strand sequences showing insertions of either T or G. E: Reverse strand sequence and underlined is the CCAAT box. Interestingly, dissimilarities of the 714insT/G were observed between the mother child pairs of the HIV-1-non-transmitting group while, either 714insG/G or mother-child pairs with similar nucleotide changes were observed among the transmitting group.
###end p 31
###begin p 32
###xml 133 138 133 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-B: </bold>
###xml 251 256 247 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C-D: </bold>
###xml 409 414 <span type="species:ncbi:9606">child</span>
###xml 427 432 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sequence electropherograms obtained from 8-3' untranslated region showing polymorphisms at nucleotide positions 3742, 3743 and 3777. A-B: Forward strand sequences and arrows indicating nucleotide changes of T-->A and G-->C. Underlined is the +/-14bp. C-D: Sequences showing a nucleotide change of C-->T indicated by arrows. Notably, C3743T sequence variant was observed at a high dissimilarity between mother-child pairs among HIV-1 non-transmitting groups.
###end p 32
###begin p 33
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C,D</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 104 112 <span type="species:ncbi:9606">children</span>
###xml 123 128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 249 254 <span type="species:ncbi:9606">child</span>
###xml 378 383 <span type="species:ncbi:9606">child</span>
###xml 407 412 <span type="species:ncbi:9606">child</span>
###xml 460 465 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 490 495 <span type="species:ncbi:9606">child</span>
###xml 516 521 <span type="species:ncbi:9606">child</span>
A heterozygous dissimilarity at nucleotide position C634G was observed between the pairs of mothers and children among the HIV-1-non-transmitting group, while homozygous similarity at nucleotide position C634C was observed among transmitting mother-child pairs in the 5'URR of the HLA-G gene (Figure 1A and 1B). Furthermore, a dissimilar insertion of either G in mother to T in child or T in mother to G in child at nucleotide position 714 was found among the HIV-1 non-transmitting mother-child pairs, while mother-child pairs with similar 714insT/G or G/G were observed among the transmitting group (Figure 1C,D and 1E).
###end p 33
###begin p 34
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 562 568 562 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A,B,C</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 625 627 625 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1007 1009 1007 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1116 1120 1116 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst </italic>
###xml 1377 1378 1377 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 168 173 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 325 330 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 669 672 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 813 818 <span type="species:ncbi:9606">child</span>
###xml 885 890 <span type="species:ncbi:9606">child</span>
###xml 959 964 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1181 1186 <span type="species:ncbi:9606">child</span>
###xml 1247 1252 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1333 1336 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1357 1362 <span type="species:ncbi:9606">child</span>
In addition, analyses of DNA variants in exon regions 2, 3, 4, 6, 7 and 8-3'UTR of the HLA-G gene were performed to elucidate the association of the polymorphisms with HIV-1 transmission and results are shown in Table 1. There were no statistically significant associations of HLA-G gene variants in exons 3, 4, 6 and 7 with HIV-1-perinatal transmission among our studied samples (Table 2). In contrast, there was a statistically significant association of dissimilarity of the HLA-G DNA sequence variants among our studied exon 8-3'UTR samples (Table 2; Figure 2A,B,C and 2D) at nucleotide positions T3742A, C3743T, G3777C (P = 0.001) with decreased risk of perinatal HIV transmission. Dissimilarities in the HLA-G exon 8-3'UTR at nucleotide position C3743T was highly frequent among the non-transmitting mother-child pairs, 85.7% (12/14-were dissimilar) than the transmitting mother-child pairs 14.3% (2/14-were dissimilar) with decreased risk of perinatal HIV-1 transmission (OR 0.02 [95% CI, 0.00-0.15] P = 0.00001). Validation of the amplified PCR products spanning HLA-G exons 6, 7, and 8-3'UTR by RFLP, using Pst I restriction enzyme resulted in 85.7% (12/14) of the mother-child pairs showing dissimilarities of banding profiles among the HIV-1-non-transmitting group and 90% (18/20) similarity of banding profiles among the HIV-transmitting mother-child pairs (Figure 3).
###end p 34
###begin p 35
###xml 71 76 <span type="species:ncbi:9606">child</span>
###xml 105 110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HLA-G DNA sequence variant dissimilarities/similarities between Mother-child pairs and risk of perinatal HIV-1 transmission
###end p 35
###begin p 36
*Percentage of similarity and dissimilarity; N, number of pairs in the given group;
###end p 36
###begin p 37
###xml 20 25 <span type="species:ncbi:9606">child</span>
###xml 159 164 <span type="species:ncbi:9606">child</span>
###xml 378 383 <span type="species:ncbi:9606">child</span>
Data from 34 mother-child pairs with HLA-G DNA sequence variants as compared to the previously published wild-type HLA 6.0 sequence by Geraghty (1987). Mother-child pairs matching with the same HLAG DNA sequence variants at the above HLA-G sequence positions are considered similar; Mother with a mismatched HLAG DNA sequence variants at one or more of these positions with the child is considered dissimilar.
###end p 37
###begin p 38
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst I</italic>
###xml 215 220 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 241 246 <span type="species:ncbi:9606">child</span>
###xml 274 279 <span type="species:ncbi:9606">child</span>
###xml 306 311 <span type="species:ncbi:9606">child</span>
###xml 333 338 <span type="species:ncbi:9606">child</span>
###xml 387 392 <span type="species:ncbi:9606">child</span>
###xml 420 425 <span type="species:ncbi:9606">child</span>
###xml 454 459 <span type="species:ncbi:9606">child</span>
###xml 483 488 <span type="species:ncbi:9606">child</span>
Representatives of digested PCR products of exons 6/7 and exon 8-3'UT region of HLA-G DNA obtained from blood samples, using restriction enzyme Pst I. M; 100-bp DNA marker, Lane 1; uncut PCR product, lane 2-7 three HIV-1-transmitting mother-child pairs (lane 2 and 3 mother-child pair, lane 4 and 5 mother-child pair; 6 and 7 mother-child pair); lane 8-13; three non transmitting mother-child pairs (lane 8 and 9 mother-child pair, lane 10 and 11 mother-child pair; 12 and 13 mother-child pair), lane 14; uncut PCR product.
###end p 38
###begin p 39
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 398 405 398 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">alpha-1</italic>
###xml 444 446 444 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 807 813 807 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 1525 1530 1525 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1534 1536 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1691 1697 1691 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 1965 1971 1965 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 2055 2061 2055 2061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 2095 2097 2095 2097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in</italic>
###xml 2098 2103 2098 2103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">utero</italic>
###xml 2217 2223 2217 2223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 2261 2263 2261 2263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2341 2347 2341 2347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 2498 2500 2498 2500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2501 2503 2501 2503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 113 118 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 513 518 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 678 683 <span type="species:ncbi:9606">human</span>
###xml 953 958 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1773 1776 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1804 1809 <span type="species:ncbi:9606">child</span>
###xml 1923 1928 <span type="species:ncbi:9606">child</span>
###xml 1945 1950 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2104 2107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
This study suggests the association of the HLA-G sequence variants with increased or decreased risk of perinatal HIV-1 transmission. All mutations observed in this study are present in the HLA-G mRNA isoforms and these mRNA isoforms are abundant transcripts in the placental tissue [7]. Previously, we have reported the association of a conservative mutation in HLA-G exon 2 (which encodes for the alpha-1-domain), (OR, 0.5 [95% CI, 0.00-0.47] p = 0.003) codon 57 with increased risk of perinatal transmission of HIV-1 [9]. Although, the mutation in exon 2 region was considered as a silent mutation, a study by Duan et al., [17] has demonstrated that a silent mutation effects human dopamine receptor D2 stability and synthesis of the receptor. In contrast, a study by Matte et al., [18] that investigated HLA-G gene concordance/discordance in African population of MTCT found no association of the mutation in exon 2 region at codon 57 with perinatal HIV-1 transmission. The striking difference in the results may be explained by the population structure used in their study (90% of the subjects in their study were of Shona ethnicity, which may represent a homogenous ancestral group or considered an isolated population). In general, homogeneous populations have relatively low frequencies of genetic variability than the heterogeneous populations and certain mutations may not play a role in disease protection in isolated populations compared to mixed populations. Furthermore, the apparent discrepancies between Matte et al., [18] study and our previous results could be further attributed to the definition of concordance and discordance. Nevertheless, this study data suggests that HLA-G gene mutations in the 5'URR alone or in combination with exon 8-3'UTR among HIV infected mother/uninfected child pairs that exhibited mismatching in the HLA-G DNA sequence may be associated with decrease in the risk of mother-child transmission of HIV-1. Mutations in HLA-G gene, particularly in 3' UTR region, may enhance the reduction of the expression of HLA-G gene and hence play a role in the in-utero-HIV infectivity. A study has demonstrated that 14-bp deletion-insertion polymorphisms in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability [19]. Other studies have shown that down regulation of the surface expression of HLA-G gene by viral immunoevasion of the placental MHC class I molecules like herpes simplex and cytomegalovirus results in viral replication and infection [20,21].
###end p 39
###begin p 40
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 747 752 747 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 770 775 770 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1436 1437 1436 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1439 1440 1439 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1699 1705 1699 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
Surprisingly, we did not observe any previously described polymorphisms by Ober [22] and Matte [23], except one polymorphism reported by Hviid [8] at 714insG in the portion of the studied sequence of the untranslated regulatory and full length of exon 1 regions of the HLA-G gene. Nevertheless, 98-99% of the same regions in our study matched with the previously published sequence of that region by Geraghty et al., [16]. We observed six and four nucleotide sequence variations within exon 3 and exon 4 regions respectively. This is a striking difference between this study and previously reported 31 variations in exon 3 by van der Ven et al., [15,24]. However, the number of variations in exon 3 region was similar to those reports by Ishitani et al., [25] and Matte et al., [23]. Of note is that all the observed nucleotide changes in exon 4 region resulted in amino acid changes and three of the six observed nucleotide changes in exon 3 region resulted in amino acid change as well. No nucleotide variation was observed in exons 6 and 7 regions. An insertion of C at position 3401 in intron 6 region and three nucleotide changes, G3579A, G3585T, and C3619G, in intron 7 were observed in our samples. In exon 8-3' UTR, we observed four nucleotide changes including the 14-bp insertion/deletion. To our knowledge, these nucleotide changes in introns 6, 7 and the two nucleotide changes at 3742 and 3743 positions of 8-3'UTR (Tables 1, 2) have not been previously reported. The polymorphisms at nucleotide positions 3742 and 3743 that were observed in some sequences of our studied samples with the 14-bp deletions, may be considered as a precursor to the occurrence of the 14-bp deletion in the HLA-G gene and could possibly influence mRNA stability.
###end p 40
###begin p 41
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 710 716 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1034 1040 1034 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 1043 1045 1043 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 1868 1870 1868 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 139 144 <span type="species:ncbi:9606">child</span>
###xml 148 153 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 256 259 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1134 1139 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1225 1230 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1568 1573 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Interestingly, the dissimilarity of the HLA-G sequence variants at nucleotide position C634G and 714insT/G observed between the mother and child of HIV-1-non-transmitting group may be in linkage disequilibrium with another variant that confers low risk of HIV perinatal transmission. Although we do not have functional data to correlate this assumption, these polymorphisms identified in 5' URR of HLA-G gene in this study, may play an important role in the pre-transcription due to the location of these variants, which are up and downstream of the CCAAT box respectively. In addition, the 714insT or G is closely flanked by an interferon response factor-1 binding motif at the upstream regulatory element of HLA-G gene. Taken together, the data from this study fits the "Trojan exosome hypothesis" to some degree, which predicts relatively efficient retroviral transmission between individuals who are histocompatible and relatively inefficient retroviral transmission between individuals who are histoincompatible [26]. Given that HLA-G gene is primarily expressed during fetal life, it could be envisaged that during gestation, a HIV-1-infected mother could transmit the virus to her fetus. This intrauterine exposure to HIV-1 virus may be a powerful selective force that could result in a polymorphism advantage at this HLA-G locus of fetuses, which can be presented with a wider variety of foreign peptides to the T-cell receptors. As a result, fetuses with a high similarity of HLA-G sequence variants with their mothers may be more susceptible to intrauterine HIV-1 infection compare to fetuses with HLA-G sequence variants that are relatively dissimilar but unlikely to be recognized as foreign by the maternal immune system. This deduced scenario is similar to the previously hypothesized scenario by van der Ven and Ober regarding HLA-G allogenic response [15].
###end p 41
###begin title 42
Conclusion
###end title 42
###begin p 43
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 345 354 345 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-utero </italic>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 220 225 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 354 359 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 675 680 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Based on these results, it is increasingly clear that HLA-G variants in exon 8-UTR, either alone or in combination with exon 2 codon 57 that was previously reported [9] and the 5' UTR could influence the risk of MTCT of HIV-1 infection. In addition, it is tempting to speculate that these observed HLA-G sequence variants may play a role in the in-utero HIV-1 transmission, even in the presence of other recognized risk factors [27-30]. However, the limited sample size of this data set suggests that the results should be interpreted cautiously. Future studies are required in a larger population of samples to determine the full impact of these HLA-G variants in perinatal HIV-1 transmission.
###end p 43
###begin title 44
Declaration of competing interests
###end title 44
###begin p 45
The author(s) declare that they have no competing interests.
###end p 45
###begin title 46
Authors' contributions
###end title 46
###begin p 47
FOA conceived, designed the study and carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. KK participated in acquisition of data, sequence alignment, drafted and reviewed the manuscript. FS performed the statistical analysis. VB participated in the design and helped to review the manuscript. All authors read and approved the final manuscript.
###end p 47
###begin title 48
Acknowledgements
###end title 48
###begin p 49
###xml 184 192 <span type="species:ncbi:9606">patients</span>
The authors would like to thank Dr. S. Mehrabi and Yang for their technical assistance. Also, we are indebted to the Perinatal AIDS Collaborative Transmission Study (PACTS) groups and patients for their participation in this study. This work was supported in part by grants from NIH-NICHD 5R03HD4408, NIH-MBRS-S06-GM008248, NIH-NCRR-RCMI G12 RR03034 and NIH-NCRR-RCMI G12 RR03034. The PACTS Prospective Cohort Study in New York City was supported by cooperative agreement: #U64 CCU 200937 with the Centers for Disease Control and Prevention.
###end p 49
###begin article-title 50
###xml 0 6 <span type="species:ncbi:9606">Infant</span>
###xml 28 33 <span type="species:ncbi:9606">women</span>
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infant feeding practices of women in a perinatal HIV-1 Prevention Study in Nairobi, Kenya
###end article-title 50
###begin article-title 51
###xml 24 29 <span type="species:ncbi:9606">child</span>
###xml 46 49 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe
###end article-title 51
###begin article-title 52
###xml 37 42 <span type="species:ncbi:9606">child</span>
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Antiretroviral therapy and mother-to-child transmission of HIV-1
###end article-title 52
###begin article-title 53
Common perinatal insults diminish cord blood RANTES
###end article-title 53
###begin article-title 54
###xml 41 69 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model
###end article-title 54
###begin article-title 55
###xml 39 44 <span type="species:ncbi:9606">human</span>
A class I antigen, HLA-G, expressed in human trophoblasts
###end article-title 55
###begin article-title 56
###xml 98 103 <span type="species:ncbi:9606">human</span>
Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast
###end article-title 56
###begin article-title 57
Polymorphisms in the regulatory region located more than 1.1 Kilobase 5' to the start site of transcription, the promoter region and exon 1 of the HLA-G gene
###end article-title 57
###begin article-title 58
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmission
###end article-title 58
###begin article-title 59
###xml 7 12 <span type="species:ncbi:9606">child</span>
###xml 56 91 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mother-child class 1 HLA concordance increase perinatal human immunodeficiency virus type 1 transmission
###end article-title 59
###begin article-title 60
###xml 71 106 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission
###end article-title 60
###begin article-title 61
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines
###end article-title 61
###begin article-title 62
###xml 14 43 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with ant-HLA Class I antibody response
###end article-title 62
###begin article-title 63
###xml 64 67 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Impact of zidovudine use on risk and risk factors for perinatal HIV. Perinatal AIDS Collaborative Transmission Studies
###end article-title 63
###begin article-title 64
HLA-G Polymorphisms in African Americans
###end article-title 64
###begin article-title 65
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human major histocompatibility complex class 1 gene that encodes a protein with a shortened cytoplasmic segment
###end article-title 65
###begin article-title 66
###xml 28 33 <span type="species:ncbi:9606">human</span>
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
###end article-title 66
###begin article-title 67
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mother-to-child human leukocyte antigen G concordance: no impact on the risk of vertical transmission of HIV-1
###end article-title 67
###begin article-title 68
The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability
###end article-title 68
###begin article-title 69
###xml 85 90 <span type="species:ncbi:9606">human</span>
Herpes simplex virus blocks intracellular transport of HILA-G in placentally derived human cells
###end article-title 69
###begin article-title 70
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules
###end article-title 70
###begin article-title 71
Variation in the HLA-G promoter region influences miscarriage rates
###end article-title 71
###begin article-title 72
ZVITAMBO Study Group. HLA-G exhibits low level of polymorphism in indigenous East Africans
###end article-title 72
###begin article-title 73
HLA-G polymorphisms: ethnic differences and implications for potential molecular function
###end article-title 73
###begin article-title 74
Re-examination of HLA-G polymorphism in African Americans
###end article-title 74
###begin article-title 75
The Trojan exosome hypothesis
###end article-title 75
###begin article-title 76
###xml 64 69 <span type="species:ncbi:9606">child</span>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Advances and research directions in the prevention of mother-to-child HIV-1 transmission
###end article-title 76
###begin article-title 77
###xml 40 45 <span type="species:ncbi:9606">child</span>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Advances in the prevention of mother-to-child HIV-1 transmission: Current issues, future challenges
###end article-title 77
###begin article-title 78
###xml 9 12 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 135 141 <span type="species:ncbi:9606">infant</span>
Maternal HIV-1viral load and vertical transmission of infection: Ariel Project for the prevention of HIV-1 transmission from mother to infant
###end article-title 78
###begin article-title 79
###xml 28 31 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 60 66 <span type="species:ncbi:9606">infant</span>
Understanding the timing of HIV transmission from mother to infant
###end article-title 79

